News

Wilmer leads in best research category

Improvement was seen with experience gained, show data from comparative study

Device is noninvasive, nonthreatening; does not require topical or general anesthesia

Level of evidence is decent, but may not be applicable to all racial, ethnic groups

Screening recipes should ease the diagnostic burden in this patient population

Video game helps youth with cerebral visual impairment

There is need for alternative treatment to circumvent current treatment limitations

Joint event to feature plenty of symposia, practice management programs, product innovations

Whether we like it or not, artificial intelligence has arrived

Orbital and adnexal anatomy and pathology can affect IOP and its measurement as well as planning of glaucoma surgery, and these structures can be affected by medical and surgical treatment of glaucoma

Optical coherence tomography angiography is finding new uses in glaucoma, as it can depict loss of blood vessels around the optic nerve and distinguish vascular layers.

A study of patients undergoing corneal crosslinking (CXL) for keratoconus suggests gene expression and tear inflammatory profile may be used as biomarkers to predict CXL outcomes.

In a study including data from 67 eyes, the majority of keratoconus indices measured by two commercially available Scheimpflug devices did not effectively differentiate normal high astigmatism from subclinical keratoconus.

Treatment should focus on the underlying etiology behind these processes

Shortcomings in ablative procedures mean that new developments in refractive surgery are welcome. Arthur Cummings, MD, FRCSEd, reviews two new technologies that will increase patient satisfaction.

Topical cenegermin has been approved by the FDA for the treatment of moderate-to-severe neurotrophic keratitis (NK), ushering in a breakthrough of management.

“The only difference between death and taxes is that death doesn’t get worse every time Congress meets.” - Will Rogers

Here's how your practice can utilize Facebook to reach out and spread the word about how you can help people with glaucoma.